ResApp Health (ASX:RAP) Presentation, CEO Sessions Sydney

Company Presentations

by Carolyn Herbert

ResApp Health (ASL:RAP) is developing digital healthcare solutions to assist doctors and empower patients to diagnose and manage respiratory disease.

Revolutionary technology:
- diagnosis and management of respiratory disease via smartphone -- without the need for additional hardware

Compelling clinical evidence:
-Very high accuracy from multiple adult and paediatric clinical studies, over 1,800 patients enrolled to date

Clear US regulatory pathway
-Held successful US FDA Pre-Submission meeting in 1Q2016
-Commenced pivotal US clinical study, SMARTCOUGH-C, at top-tier hospitals to support de novo submission

US market entry in 2017:
-Launch via US telehealth partner to reach millions of patients quickly
-Potential European, Australian and Asian market entry in parallel to US
-Deployment to low resource areas via partnerships with humanitarian organisations

Carolyn Herbert

Finance News Network
Carolyn joined FNN in August 2015 as the Head of News and also presented the Market at Midday and the Market Wrap. With more than five years of broadcast journalism experience, Carolyn has worked as a finance anchor on the Sky News Business channel and as an anchor and reporter for ABC News. She is also a qualified corporate lawyer specialising in IPOs, takeovers and mergers and acquisitions.